Abstract
Integrase is essential for human immunodeficiency virus-type 1 (HIV-1) replication; however, potent inhibition of the isolated enzyme in biochemical assays has not readily translated into antiviral activity in a manner consistent with inhibition of integration. In this report, we describe diketo acid inhibitors of HIV-1 integrase that manifest antiviral activity as a consequence of their effect on integration. The antiviral activity of these compounds is due exclusively to inhibition of one of the two catalytic functions of integrase, strand transfer.
MeSH terms
-
Acetoacetates / chemistry
-
Acetoacetates / metabolism
-
Acetoacetates / pharmacology*
-
Anti-HIV Agents / chemistry
-
Anti-HIV Agents / metabolism
-
Anti-HIV Agents / pharmacology*
-
Catalysis / drug effects
-
Coculture Techniques
-
DNA, Circular / biosynthesis
-
DNA, Circular / metabolism
-
DNA, Viral / biosynthesis
-
DNA, Viral / metabolism
-
Drug Resistance, Microbial
-
HIV Integrase / genetics
-
HIV Integrase / metabolism*
-
HIV Integrase Inhibitors / chemistry
-
HIV Integrase Inhibitors / metabolism
-
HIV Integrase Inhibitors / pharmacology*
-
HIV Long Terminal Repeat / drug effects
-
HIV-1 / drug effects*
-
HIV-1 / enzymology
-
HIV-1 / genetics
-
HIV-1 / physiology
-
Humans
-
Mutation
-
Pyrroles / chemistry
-
Pyrroles / metabolism
-
Pyrroles / pharmacology*
-
Recombinant Proteins / antagonists & inhibitors
-
Recombinant Proteins / metabolism
-
T-Lymphocytes / virology
-
Transcription, Genetic
-
Tumor Cells, Cultured
-
Virus Integration / drug effects*
-
Virus Replication / drug effects
Substances
-
Acetoacetates
-
Anti-HIV Agents
-
DNA, Circular
-
DNA, Viral
-
HIV Integrase Inhibitors
-
L 708906
-
L 731988
-
Pyrroles
-
Recombinant Proteins
-
HIV Integrase